Description
Recommended first-line treatment with atypical antipsychotic medication for management of schizophrenia and other psychotic disorders is contributory to weight gain and associated comorbidities. Beyond comorbid conditions – weight gain can lead to poor self-image, poor compliance and treatment outcomes in an already stigmatized population.
Download count: 0
Details
Contributors
- Graeber, Laura (Author)
- Chen, Angela Chia-Chen (Thesis advisor)
Date Created
The date the item was original created (prior to any relationship with the ASU Digital Repositories.)
2018-04-30
Resource Type
Collections this item is in
Collaborating institutions